ENDOSTATIN PEPTIDE, AN INHIBITOR OF ANGIOGENESIS, AMELIORATES RENAL ALTERATIONS IN THE EARLY STAGE OF DIABETIC NEPHROPATHY

被引：0
|
作者：
Ichinose, Kunihiro [1 ]
Maeshima, Yohei [1 ]
Yamamoto, Yoshihiko [1 ]
Kitayama, Hiroyuki [1 ]
Takazawa, Yuki [1 ]
Hirokoshi, Kumiko [1 ]
Sugiyama, Hitoshi [1 ]
Yamasaki, Yasushi [1 ]
Makino, Hirofumi [1 ]
机构：
[1] Okayama Univ, Grad Sch Med & Dent, Dept Med & Clin Sci, Okayama 7008530, Japan
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A30 / A30
页数：1
相关论文
共 50 条
  • [1] Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model
    Ichinose, K
    Maeshima, Y
    Yamamoto, Y
    Kitayama, H
    Takazawa, Y
    Hirokoshi, K
    Sugiyama, H
    Yamasaki, Y
    Eguchi, K
    Makino, H
    DIABETES, 2005, 54 (10) : 2891 - 2903
  • [2] Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model (vol 54, pg 2891, 2005)
    Ichinose, K.
    Maeshima, Y.
    Yamamoto, Y.
    Kitayama, H.
    Takazawa, Y.
    Hirokoshi, K.
    Sugiyama, Hitoshi
    Yamasaki, Y.
    Eguchi, K.
    Makino, H.
    DIABETES, 2006, 55 (09) : 2665 - 2665
  • [3] Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy
    Yamamoto, Y
    Maeshima, Y
    Kitayama, H
    Kitamura, S
    Takazawa, Y
    Sugiyama, H
    Yamasaki, Y
    Makino, H
    DIABETES, 2004, 53 (07) : 1831 - 1840
  • [4] Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
    Nasu, Tatsuyo
    Maeshima, Yohei
    Kinomura, Masaru
    Hirokoshi-Kawahara, Kumiko
    Tanabe, Katsuyuki
    Sugiyama, Hitoshi
    Sonoda, Hikaru
    Sato, Yasufumi
    Makino, Hirofumi
    DIABETES, 2009, 58 (10) : 2365 - 2375
  • [5] Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early state of diabetic nephropathy.
    Yamamoto, Y
    Maeshima, Y
    Kitayama, H
    Kitamura, S
    Sugiyama, H
    Kalluri, R
    Yamasaki, Y
    Makino, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 318A - 318A
  • [6] PHYSIOLOGICAL LEVELS OF ENDOSTATIN SUPPRESS RENAL INJURY IN DIABETIC NEPHROPATHY
    Hamano, Yuki
    Udagawa, Yuki
    Ueda, Yoshihiko
    Yokosuka, Osamu
    Ogawa, Makoto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 161 - 161
  • [7] Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
    Yun-Yan Wan
    Guang-Yan Tian
    Hai-Sheng Guo
    Yan-Meng Kang
    Zhou-Hong Yao
    Xi-Li Li
    Qing-Hua Liu
    Dian-Jie Lin
    Respiratory Research, 14
  • [8] Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
    Wan, Yun-Yan
    Tian, Guang-Yan
    Guo, Hai-Sheng
    Kang, Yan-Meng
    Yao, Zhou-Hong
    Li, Xi-Li
    Liu, Qing-Hua
    Lin, Dian-Jie
    RESPIRATORY RESEARCH, 2013, 14
  • [9] Estrogen ameliorates renal pathology and renal function in diabetic nephropathy
    Maric, C
    Bhatti, F
    Ratner, R
    Howard, B
    Sandberg, K
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 126A - 126A
  • [10] Vascular repair is vulnerable to renal regeneration in early stage of diabetic nephropathy
    Futrakul, Narisa
    Futrakul, Prasit
    ASIAN BIOMEDICINE, 2010, 4 (05) : 827 - 828
12345